Company profile: DNAfit
1.1 - Company Overview
Company description
- Provider of at-home DNA testing and genetic insights for health, fitness, and nutrition. Offerings include CircleDNA Premium (500+ reports via saliva swab), genetic carrier screening, disease and cancer risk overviews, diet and fitness reports, skin predisposition insights, and success trait summaries to help personalize exercise, nutrition, and skincare choices.
Products and services
- CircleDNA Premium: An at-home saliva-swab DNA test delivering 500+ reports across diet, nutrition, sports, cancer and disease risk profiles, plus carrier conditions
- Disease & Cancer Screening: A genetics-based risk assessment overview that identifies your genetic health risks for various diseases and cancers, enabling early action
- Genetic Carrier Screening: Carrier-status screening that reveals whether you carry over 160 serious heritable conditions, helping you make informed decisions for your family's well-being
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DNAfit
BioChain
HQ: United States
Website
- Description: Provider of technology and products for the life science research community, including cfPure® cell-free DNA extraction kits to isolate cfDNA from plasma, serum, and urine for NGS and PCR; high-quality biospecimens; reagents; pre-packaged laboratory kits; and automated instruments to automate processes and enhance efficiency in sample preparation and analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioChain company profile →
Caris Life Sciences
HQ: United States
Website
- Description: Provider of molecular profiling and AI-driven precision oncology solutions, offering tissue-based profiling, specimen testing services to identify molecular cancer characteristics for personalized treatment, shipper kits for specimen transport, and billing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caris Life Sciences company profile →
Epimeron
HQ: United States
Website
- Description: Provider of gene discovery, deployment, and optimization solutions that support important plant biochemical functions required for maximum product yield.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epimeron company profile →
Medicinal Genomics
HQ: The Netherlands
Website
- Description: Provider of genomics-driven testing and breeding solutions for medical cannabis and hemp, including the PathoSEEK qPCR-based microbial safety testing platform and detection assays for flower, extracts, and infused products; SenSATIVAx DNA purification kits; FemINDICAtor qPCR plant sex testing; and genomic services to identify markers for desirable traits and accelerate breeding programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicinal Genomics company profile →
Strata Oncology
HQ: United States
Website
- Description: Provider of precision oncology solutions, including Strata Select, a DNA/RNA-based molecular profiling test guiding immunotherapy and other treatment selection for advanced cancer; the Immunotherapy Response Score predicting benefit of anti-PD-1/PD-L1 monotherapy; and clinical trials such as Strata PATH and Strata Trial enabling biomarker-guided evaluation and access to approved and investigational therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Strata Oncology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DNAfit
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DNAfit
2.2 - Growth funds investing in similar companies to DNAfit
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DNAfit
4.2 - Public trading comparable groups for DNAfit
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →